Researchers reprogram fat-derived stem cells to act as biologic pacemakers
The free daily newsletter covering the top cardiovascular headlines
Related Articles
CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern
The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for…
Yes, researchers argue, vitamin D supplements help protect the heart
The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.
Update to Johnson & Johnson PFA platform gains FDA approval
The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the…
AI-enhanced echocardiography improves early detection of cardiac amyloidosis
The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.
FDA approves Bayer’s finerenone to treat wide range of heart failure patients
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has…
FDA details multiple Class I recalls for Edwards Lifesciences surgical devices
Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have…
ASE shares new recommendations for evaluating LV diastolic function, HFpEF
The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.
AI-enabled coronary plaque evaluations included in new RBM guidelines
The use of advanced AI software to assess CCTA images continues to gain more momentum.
Myval TAVR valve associated with positive durability data after 4 years
Researchers have been spending more and more time evaluating the Myval TAVR valve from Indian medtech company Meril Life Sciences. The balloon-expandable device is available…
CMS proposes Medicare coverage for renal denervation
This proposal, if finalized, would dramatically increase patient access to renal denervation. Both Recor Medical and Medtronic have shared their excitement over the news.